Abstract
1 Plasma oxprenolol concentrations were measured in six young healthy female volunteers after single oral dosing with a 16/260 oxprenolol Oros system on three separate occasions. Reproducibility was assessed by comparing individual plasma profiles, areas under the curve, peak concentrations and times to peak.
2 Plasma concentration-time profiles were consistent with an extended duration of drug release from the Oros system. Individual and mean profiles on the three occasions were similar, and no significant differences in mean plasma levels, or derived pharmacokinetic parameters, were detected.
3 The mean amount of drug in eight systems recovered from faeces corresponded to 11% of the dose. Individual amounts were related to the total transit time of the system through the body.
4 The 16/260 Oros system functioned reproducibly within the gastrointestinal tract, and in vivo absorption mirrored in vitro drug release.
Keywords: oxprenolol, Oros dosage form, plasma concentration, reproducibility
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bennett P. N., Bennett J., Bradbrook I., Francis J., John V. A., Rogers H., Turner P., Warrington S. J. Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers. Br J Clin Pharmacol. 1985;19 (Suppl 2):171S–175S. doi: 10.1111/j.1365-2125.1985.tb02758.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cummings J. H., Jenkins D. J., Wiggins H. S. Measurement of the mean transit time of dietary residue through the human gut. Gut. 1976 Mar;17(3):210–218. doi: 10.1136/gut.17.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jack D. B., Quarterman C. P., Zaman R., Kendall M. J. Variability of beta-blocker pharmacokinetics in young volunteers. Eur J Clin Pharmacol. 1982;23(1):37–42. doi: 10.1007/BF01061375. [DOI] [PubMed] [Google Scholar]
- SCHANKER L. S. Absorption of drugs from the rat colon. J Pharmacol Exp Ther. 1959 Aug;126:283–290. [PubMed] [Google Scholar]
- Theeuwes F., Swanson D. R., Guittard G., Ayer A., Khanna S. Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration. Br J Clin Pharmacol. 1985;19 (Suppl 2):69S–76S. doi: 10.1111/j.1365-2125.1985.tb02745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Woods K. L., Jack D. B., Kendall M. J., Halsey A., O'Donnell M. L., Warrington S. J., John V. A. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers. Br J Clin Pharmacol. 1985;19 (Suppl 2):177S–184S. doi: 10.1111/j.1365-2125.1985.tb02759.x. [DOI] [PMC free article] [PubMed] [Google Scholar]